Mitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategies.
about
Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease.[18F]FP-(+)-DTBZ PET study in a lactacystin-treated rat model of Parkinson disease.Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.
P2860
Mitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mitochondrial toxins in Basal ...... els to therapeutic strategies.
@en
Mitochondrial toxins in Basal ...... els to therapeutic strategies.
@nl
type
label
Mitochondrial toxins in Basal ...... els to therapeutic strategies.
@en
Mitochondrial toxins in Basal ...... els to therapeutic strategies.
@nl
prefLabel
Mitochondrial toxins in Basal ...... els to therapeutic strategies.
@en
Mitochondrial toxins in Basal ...... els to therapeutic strategies.
@nl
P2093
P2860
P50
P1476
Mitochondrial toxins in Basal ...... dels to therapeutic strategies
@en
P2093
P2860
P356
10.2174/157015906775203039
P577
2006-01-01T00:00:00Z